logo

For the Inventor, By the Inventor

Kingston, Canada

Michael A Adams

USPTO Granted Patents = 26

Average Co-Inventor Count = 2.9

ph-index = 14

Forward Citations = 582(Granted Patents)


Company Filing History:

goldMedal20 out of 415 
 
Queen's University at Kingston
 patents
silverMedal3 out of 19 
 
Cellegy Pharmaceuticals Inc.
 patents
bronzeMedal2 out of 18 
 
Pentech Pharmaceuticals, Inc.
 patents
4. 1 out of 1 
 
Cellegy Canada
 patent
5. 1 out of 2 
 
Strakan International Limited
 patents
6. 1 out of 832,891 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2012

Loading Chart...
26 patents (USPTO):Explore Patents
1. 8168232 - Formulations and methods of using nitric oxide mimetics in cancer treatment (2012-05-01),
2. 7678391 - Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype (2010-03-16),
3. 7393825 - Microdose therapy (2008-07-01),
4. 6946484 - Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype (2005-09-20),
5. 6787553 - Methods for remodeling neuronal and cardiovascular pathways (2004-09-07),
6. 6756407 - Method and compositions for the treatment or amelioration of female sexual dysfunction (2004-06-29),
7. 6747063 - Combination therapy for treatment of erectile dysfunction (2004-06-08),
8. 6713527 - Anaesthetic bone cement (2004-03-30),
9. 6635648 - Combination therapy using sympathetic nervous system antagonists and endothelin antagonists (2003-10-21),
10. 6610652 - Microdose therapy (2003-08-26),
11. 6586478 - Methods and compositions for improving sleep (2003-07-01),
12. 6586391 - Method of ameliorating erectile dysfunction (2003-07-01),
13. 6458797 - Methods for remodeling neuronal and cardiovascular pathways (2002-10-01),
14. 6423683 - Microdose therapy (2002-07-23),
15. 6410007 - Antagonism of endothelin actions (2002-06-25),

Title: Michael A Adams: Pioneering Innovations in Cancer Treatment

Introduction:

Michael A Adams is a visionary inventor based in Kingston, CA, renowned for his groundbreaking contributions to the field of cancer treatment. With an impressive track record of 26 patents, Adams is a beacon of innovation whose work continues to impact society and the environment positively.

Latest Patents:

Among his latest patents are formulations and methods for using nitric oxide mimetics in cancer treatment. These innovative approaches aim at inhibiting, treating, and preventing malignant cell phenotypes, tumors, and diseases by restoring nitric oxide-mediated signaling. Particularly effective in animal cancer treatment, Adams' inventions hold significant promise for the medical community.

Career Highlights:

Adams has left an indelible mark through his work at esteemed institutions such as Queen's University at Kingston and Cellegy Pharmaceuticals Inc. His dedication to pushing boundaries in cancer treatment has led to the development of revolutionary methodologies, transforming the landscape of medical research and patient care.

Collaborations:

Throughout his career, Adams has collaborated with esteemed professionals like Jeremy P W Heaton and James D Banting. Together, they have synergized their expertise to drive forward innovative solutions that have the potential to revolutionize cancer treatment and care.

Conclusion:

Michael A Adams' relentless pursuit of innovation in cancer treatment underscores his commitment to improving lives and advancing the field of medicine. His remarkable patents and collaborations continue to inspire inventors and researchers globally, solidifying his reputation as a trailblazer in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…